World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
37493
World Ranking
9976
National Ranking
965

Overview

William P. Steward is affiliated with the University of Leicester in the United Kingdom. Their academic profile primarily focuses on scientific research but currently does not display detailed records of published papers, coauthors, or specific fields of study. No information on main or subfields of study is available to elaborate on their scholarly specialization.

There are no listed recent publications attributed to William P. Steward, and no data is provided concerning frequent publication venues. As a result, it is not possible to detail any significant patterns of research dissemination or preferred academic journals.

Similarly, no frequent co-authors are recorded, indicating either independent work or absence of documented collaboration history. Details on their book publications or associations with publishers are also not available.

William P. Steward's research focus topics and thematic areas have not been specified within the available data. There is no record of awards or honors linked to their academic career.

The absence of specified research topics or fields indicates limited public data on their research contributions or scientific impact at this stage. The profile is based strictly on the current available information without extrapolation beyond these records.

Best Publications

  • Curcumin: The story so far

    R.A. Sharma;A.J. Gescher;W.P. Steward

  • Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance

    Ricky A. Sharma;Stephanie A. Euden;Sharon L. Platton;Darren N. Cooke

  • Pharmacodynamic and Pharmacokinetic Study of Oral Curcuma Extract in Patients with Colorectal Cancer

    Ricky A. Sharma;Heather R. McLelland;Kirsti A. Hill;Christopher R. Ireson

  • Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

    David J. Boocock;Guy E.S. Faust;Ketan R. Patel;Anna M. Schinas

  • Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

    David Cunningham;Ian Chau;Deborah D. Stocken;Juan W. Valle

  • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

    John K Ramage;A Ahmed;J Ardill;N Bax

  • Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics and Effect on the Insulin-like Growth Factor Axis

    Victoria A. Brown;Ketan R. Patel;Maria Viskaduraki;James A. Crowell

  • Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production

    Christopher Ireson;Samantha Orr;Don J. L. Jones;Richard Verschoyle

  • Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine

    Christopher R. Ireson;Donald J. L. Jones;Samantha Orr;Michael W. H. Coughtrie

  • Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

    A Santoro;T Tursz;H Mouridsen;Jaap Verweij

  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies

    Bruno Morgan;Anne L. Thomas;Joachim Drevs;Juergen Hennig

  • Structure and function of heparan sulphate proteoglycans

    John T Gallagher;Malcolm Lyon;William P Steward

  • Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.

    Giuseppe Garcea;David P Berry;Donald J L Jones;Raj Singh

  • Clinical trials of resveratrol

    Ketan R. Patel;Edwina Scott;Victoria A. Brown;Andreas J. Gescher

  • Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients

    Ketan R. Patel;Victoria A. Brown;Donald J.L. Jones;Robert G. Britton

  • PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN

    Ricky A. Sharma;William P. Steward;Andreas J. Gescher

  • Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration.

    G Garcea;D J L Jones;R Singh;A R Dennison

  • Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties

    Sarah C. Thomasset;David P. Berry;Giuseppe Garcea;Timothy Marczylo

  • Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

    Timothy H. Marczylo;Richard D. Verschoyle;Darren N. Cooke;Paolo Morazzoni

  • Chemopreventive Efficacy and Pharmacokinetics of Curcumin in the Min/+ Mouse, a Model of Familial Adenomatous Polyposis

    Sarah Perkins;Richard D. Verschoyle;Kirsti Hill;Ifat Parveen

Frequent Co-Authors

Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology
Peter B. Farmer
Peter B. Farmer University of Leicester
Keith R. Abrams
Keith R. Abrams University of Leicester
Nick Thatcher
Nick Thatcher University of Manchester
Angus G. Dalgleish
Angus G. Dalgleish St George's, University of London
adrian l harris
adrian l harris University of Oxford
Juan W. Valle
Juan W. Valle University of Manchester
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
Bertram Wiedenmann
Bertram Wiedenmann Charité - University Medicine Berlin
Lawrence J. Marnett
Lawrence J. Marnett Vanderbilt University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a traditional route, there is a growing demand for flexible, online healthcare degrees. For those interested in mental health care, psych nurse practitioner programs enable registered nurses to specialize in psychiatric services through convenient, online study. These programs offer a direct pathway to advanced practice and specialized patient care.

Administrative roles in healthcare also present promising career options. Pursuing an affordable healthcare administration degree online allows students to advance into management without the high costs of on-campus programs. Graduates can work in hospital administration, healthcare consulting, and policy development.

If you are considering graduate study, cheap mha programs make earning a Master’s in Healthcare Administration more accessible, preparing you for leadership roles in various medical organizations. For nurses aiming for top clinical positions, the most affordable dnp programs offer a cost-effective way to earn a Doctor of Nursing Practice degree online.

Best Scientists Citing William P. Steward

Trending Scientists

Recently Published Articles